World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
59915
World Ranking
8734
National Ranking
265

Raoul Herbrecht publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Raoul Herbrecht sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 431 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Raoul Herbrecht D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Raoul Herbrecht sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 98 D-Index — 57th percentile

57% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Raoul Herbrecht is affiliated with the University of Strasbourg in France and has contributed extensively to research in medicine, with a particular focus on infectious diseases, epidemiology, oncology, hematology, and cell biology. Their work encompasses over 100 publications, prominently addressing fungal infections and antifungal resistance.

Their research spans several main topics including:

  • Antifungal resistance and susceptibility
  • Fungal infections and studies
  • Neutropenia and cancer infections
  • Plant pathogens and fungal diseases
  • Infectious diseases and mycology
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Mycotoxins in agriculture and food

Raoul Herbrecht has frequently published in the following venues:

  • Leukemia
  • Medical Mycology
  • British Journal of Haematology
  • Emerging Infectious Diseases
  • Infectious Diseases Now

Notable recent papers include:

  • COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA), 2021, Journal of Hematology & Oncology
  • Evaluation of Serum Mucorales Polymerase Chain Reaction (PCR) for the Diagnosis of Mucormycoses: The MODIMUCOR Prospective Trial, 2022, Clinical Infectious Diseases
  • Invasive Pulmonary Aspergillosis, 2020, Seminars in Respiratory and Critical Care Medicine
  • Antifungal Therapy: New and Evolving Therapies, 2020, Seminars in Respiratory and Critical Care Medicine
  • Voriconazole plus terbinafine combination antifungal therapy for invasive Lomentospora prolificans infections: analysis of 41 patients from the FungiScope® registry 2008-2019, 2020, Clinical Microbiology and Infection

Frequent collaborators include:

  • Fanny Lanternier
  • François Danion
  • Valérie Letscher-Bru
  • Marie-Pierre Ledoux
  • Livio Pagano

Best Publications

  • CHOP Chemotherapy plus Rituximab Compared with CHOP Alone in Elderly Patients with Diffuse Large-B-Cell Lymphoma

    Bertrand Coiffier;Eric Lepage;Josette Briere;Raoul Herbrecht

  • Revised Definitions of Invasive Fungal Disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group

    Ben De Pauw;Thomas J. Walsh;J. Peter Donnelly;David A. Stevens

  • Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis

    Raoul Herbrecht;David W. Denning;David W. Denning;Thomas F. Patterson;John E. Bennett

  • Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America

    Thomas J. Walsh;Elias J. Anaissie;David W. Denning;Raoul Herbrecht

  • Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America

    Thomas F. Patterson;George Richard Thompson;David W. Denning;Jay A. Fishman

  • Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

    A. J. Ullmann;J. M. Aguado;S. Arikan-Akdagli;D. W. Denning

  • ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients.

    O.A. Cornely;M. Bassetti;T. Calandra;J. Garbino

  • Efficacy and Safety of Voriconazole in the Treatment of Acute Invasive Aspergillosis

    David W. Denning;Patricia Ribaud;Noel Milpied;Denis Caillot

  • Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

    Johan A. Maertens;Issam I. Raad;Kieren A. Marr;Thomas F. Patterson

  • Treatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: An externally controlled trial

    Thomas J. Walsh;Issam Raad;Thomas F. Patterson;Pranatharthi Chandrasekar

  • Liposomal Amphotericin B as Initial Therapy for Invasive Mold Infection: A Randomized Trial Comparing a High–Loading Dose Regimen with Standard Dosing (AmBiLoad Trial)

    Oliver A. Cornely;Johan Maertens;Mark Bresnik;Ramin Ebrahimi

  • Imaging findings in acute invasive pulmonary aspergillosis: Clinical significance of the halo sign

    Reginald E. Greene;Haran T. Schlamm;Jörg W. Oestmann;Paul Stark

  • Phase III Study to Evaluate Temsirolimus Compared With Investigator's Choice Therapy for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma

    Georg Hess;Raoul Herbrecht;Jorge Romaguera;Gregor Verhoef

  • Isavuconazole Treatment for Mucormycosis: A Single-Arm Open-Label Trial and Case-Control Analysis

    Francisco M. Marty;Luis Ostrosky-Zeichner;Oliver A. Cornely;Kathleen M. Mullane

  • ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients

    Frederic Tissot;Samir G. Agrawal;Livio Pagano;Georgios Petrikkos

  • Posaconazole as salvage therapy for zygomycosis

    R. N. Greenberg;R. N. Greenberg;K. Mullane;J. A H Van Burik;I. Raad

  • Phase III Randomized Study of Bendamustine Compared With Chlorambucil in Previously Untreated Patients With Chronic Lymphocytic Leukemia

    Wolfgang U. Knauf;Toshko Lissichkov;Ali Aldaoud;Anna Liberati

  • European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update

    J Maertens;O Marchetti;R Herbrecht;O A Cornely

  • Defining Responses to Therapy and Study Outcomes in Clinical Trials of Invasive Fungal Diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer Consensus Criteria

    Brahm H. Segal;Raoul Herbrecht;David A. Stevens;David A. Stevens;Luis Ostrosky-Zeichner

  • A randomized comparison of liposomal versus conventional amphotericin B for the treatment of pyrexia of unknown origin in neutropenic patients.

    H. G. Prentice;I. M. Hann;R Herbrecht;M Aoun

Frequent Co-Authors

Oliver A. Cornely
Oliver A. Cornely University of Cologne
Olivier Lortholary
Olivier Lortholary Université Paris Cité
Claudio Viscoli
Claudio Viscoli University of Genoa
David W. Denning
David W. Denning University of Manchester
Catherine Cordonnier
Catherine Cordonnier Paris-Est Créteil University
John R. Wingard
John R. Wingard University of Florida
Christian Gisselbrecht
Christian Gisselbrecht Université Paris Cité
Bertrand Coiffier
Bertrand Coiffier Centre Hospitalier Lyon Sud
Paul E. Verweij
Paul E. Verweij Radboud University
Denis Caillot
Denis Caillot Grenoble Alpes University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're interested in Medicine but want flexible education options, there are several online degrees that can help you advance your career. For those aiming for healthcare leadership or administration, consider cahme accredited online mha programs. These programs ensure high-quality, accredited training for future healthcare managers.

Registered nurses who want to further their qualifications may explore online rn-bsn programs without clinicals. These are designed for working nurses seeking to complete a BSN degree online, with minimal on-campus requirements.

If you're pursuing advanced practice roles, look into accelerated dnp programs online. These programs help qualified nurses earn a Doctor of Nursing Practice quickly, sometimes in as little as one year.

For those seeking a less intensive path, reviews and recommendations on the easiest dnp program reddit can help identify streamlined DNP options that balance rigor with flexibility.

Best Scientists Citing Raoul Herbrecht

Trending Scientists

Recently Published Articles